Seffalair Spiromax is a prescription medication used in the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains a combination of two active ingredients: a corticosteroid and a long-acting beta-agonist (LABA), which work together to reduce inflammation in the lungs and relax the muscles of the airways, improving breathing and helping to prevent the symptoms associated with these respiratory conditions. Seffalair Spiromax is administered through inhalation, allowing the medication to directly reach the lungs. It is important for patients to follow their healthcare provider's instructions on how to use the inhaler correctly to ensure the medication is most effective. This medication is not intended for the relief of acute bronchospasm or as a rescue inhaler.